A Study of Online Follow-up in Patients With Papillary Thyroid Cancer
Launched by WEST CHINA HOSPITAL · Jan 28, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effectiveness of online follow-ups for patients who have had treatment for papillary thyroid cancer. The researchers want to find out if online visits can provide the same quality of care as in-person check-ups. The trial will start in August 2024 and run until August 2026, and it’s open to adults aged 18 to 90 who speak Chinese and have had thyroid surgery. Participants should be comfortable using the internet and email, and they must not have serious mental health issues or certain medical conditions that could complicate their care.
If you decide to join the trial, you will be randomly assigned to either an online follow-up group or a traditional in-person follow-up group. Throughout the study, participants will have check-ups at 1, 3, and 6 months after surgery, either online or in the clinic. The research team will collect information about your health and satisfaction with the follow-up care. They will also check in with you 30 days after your last visit to see if there were any problems after your treatment. This study aims to ensure that all patients receive the best possible care, whether online or in person.
Gender
ALL
Eligibility criteria
- • Inclusion Criteria：
- • clinical diagnosis of papillary thyroid cancer
- • has underwent thyroid surgery (including endoscopic and open thyroid surgery)
- • 18 to 90 years of age
- • spoke Chinese
- • has the ability to use mobile phones and the Internet to complete the visit
- • voluntarily participate in clinical trials and sign informed consent.
- • Exclusion Criteria：
- • postoperative hospital stay more than 5 days
- • inability to complete an online visit (no access to the device or the Internet
- • high risk of postoperative complications (recurrent laryngeal nerve injury, etc.)
- • unable to participate due to comorbidities, laboratory test results or physical disability
- • pregnancy
- • has mental illness or take psychotropic drugs, and were not able to perform the surgery
About West China Hospital
West China Hospital, affiliated with Sichuan University, is a leading medical institution renowned for its comprehensive healthcare services, advanced research initiatives, and commitment to medical education. As a prominent clinical trial sponsor, the hospital leverages its extensive resources and expertise to facilitate innovative research in various therapeutic areas. With a focus on improving patient outcomes and advancing medical knowledge, West China Hospital collaborates with various stakeholders to conduct rigorous clinical trials that adhere to the highest ethical and scientific standards. Its state-of-the-art facilities and multidisciplinary teams ensure the successful execution of trials, contributing significantly to the global healthcare landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chengdu, Sichuan, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported